Prot #SNR-05: An Adaptive, Phase II/III, Double-Blind, Randomized, Placebo-Controlled, Two-Part, Dose-Finding, Multi-Center Study of the Safety and Efficacy of NaBen® (Sodium Benzoate), a D-Amino Acid Oxidase Inhibitor, as an Add-on Therapy with Clozapine

Project: Research project

StatusActive
Effective start/end date3/14/183/14/21

Funding

  • Amarex Clinical Research (Prot #SNR-05)
  • SyneuRx International (Taiwan) Corp. (Prot #SNR-05)